Loading…
Loading…
EQUITY / NASDAQ · XNCM
Radiopharm Theranostics Limited Depositary Receipt
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →07/01/2024 – 06/30/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.42 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 1.42 USD · Volume 62,326
20 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
07/01/2024 – 06/30/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 3,633,422 USD | 299,228 USD | +1,114.27% |
| Operating profit | -38,173,865 USD | -47,209,867 USD | — |
| Net income | -38,342,457 USD | -47,949,119 USD | — |
| Operating cash flow | -36,645,477 USD | -22,975,935 USD | — |
| Cash and cash equivalents | 29,116,835 USD | 18,575,040 USD | +56.75% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end07/01/2024 – 06/30/2025ConsolidatedUnits · USD | 2024 / Year end07/01/2023 – 06/30/2024ConsolidatedUnits · USD | 2023 / Year end07/01/2022 – 06/30/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 29,116,835 USD | 18,575,040 USD | 11,699,066 USD |
| Financing cash flowCash flow statement | 45,431,548 USD | 30,196,945 USD | 9,217,791 USD |
| Gross profitIncome statement | 39,276 USD | 299,228 USD | 292,359 USD |
| Investing cash flowCash flow statement | 1,770,598 USD | -320,000 USD | -1,530,681 USD |
| Net incomeIncome statement | -38,342,457 USD | -47,949,119 USD | -34,611,194 USD |
| Operating cash flowCash flow statement | -36,645,477 USD | -22,975,935 USD | -23,201,798 USD |
| Operating profitIncome statement | -38,173,865 USD | -47,209,867 USD | -34,487,098 USD |
| RevenueIncome statement | 3,633,422 USD | 299,228 USD | 292,359 USD |
| Total assetsBalance sheet | 86,481,876 USD | 72,036,345 USD | — |
| Total equityBalance sheet | 42,871,904 USD | 27,353,286 USD | 45,579,425 USD |
| Total liabilitiesBalance sheet | 43,609,972 USD | 44,683,059 USD | — |
| Report source | Open report ↗ Published: 09/18/2025 | Open report ↗ Published: 09/18/2025 | Open report ↗ Published: 09/18/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.